Paul Moss

Publications

  1. 2020
  2. Accepted/In press
  3. Published
  4. Published
  5. Published

    "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection?

    Paul Moss, 27 May 2020, In: Immunity & Ageing. 17, 14.

    Research output: Contribution to journalArticlepeer-review

  6. Published
  7. Published
  8. Published
  9. 2019
  10. Published
  11. Published
  12. Published

    Early T cell differentiation with well-maintained function across the adult life course in sub-Saharan Africa

    David Miles, Annette Pachnio & Paul Moss, 1 Sep 2019, In: Journal of Immunology. 203, 5, p. 1160-1171 12 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
  20. 2018
  21. Published
  22. Published

    The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands

    Jianmin Zuo, Fiyaz Mohammed & Paul Moss, 16 Aug 2018, In: Frontiers in immunology. 9, 1820.

    Research output: Contribution to journalArticlepeer-review

  23. Published
  24. Published
  25. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 4 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journalArticlepeer-review

  26. E-pub ahead of print
  27. Published
  28. Published
  29. Published
  30. 2017
  31. Published
  32. Published

    Maternal effector T cells within decidua: The adaptive immune response to pregnancy?

    David Lissauer, Mark Kilby & Paul Moss, Dec 2017, In: Placenta. 60, p. 140-144

    Research output: Contribution to journalArticlepeer-review

  33. Published
  34. Published

    ULBPs: regulators of human lymphocyte stress recognition

    Jianmin Zuo, Benjamin Willcox & Paul Moss, 13 Nov 2017, In: OncoTarget.

    Research output: Contribution to journalEditorialpeer-review

  35. Published
  36. Published

    Cytomegalovirus in Patients in the Intensive Care Unit-Reply

    Paul Moss & Julian Bion, 1 Oct 2017, In: JAMA internal medicine. 177, 10, p. 1543

    Research output: Contribution to journalComment/debatepeer-review

  37. Published
  38. Published

    Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis

    Jorge Caamano, Paul Moss & Antal Rot, Jul 2017, In: Nature Immunology. 18, 7, p. 753 - 761

    Research output: Contribution to journalArticlepeer-review

  39. Published
  40. Published
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published

    The Transcription Factor Hobit Identifies Human Cytotoxic CD4(+) T Cells

    Jianmin Zuo, Paul Moss, 24 Mar 2017, In: Frontiers in immunology. 8, 325.

    Research output: Contribution to journalArticlepeer-review

  47. Published
  48. 2016
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. Published
  55. Published
  56. Published
  57. Published
  58. Published
  59. 2015
  60. Published

    TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

    Annette Pachnio, Paul Moss, 24 Dec 2015, In: Blood. 126, 26, p. 2781-2789

    Research output: Contribution to journalArticlepeer-review

  61. Published
  62. Published

    Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

    Ceri Oldreive, Nick Davies, Anna Skowronska, Marwan Cheng Kuang Kwok, Paul Moss, Michael Griffiths, Malcolm Taylor & Tatjana Stankovic, 3 Dec 2015, Blood. American Society of Hematology, Vol. 126. p. 167 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  63. Published
  64. E-pub ahead of print
  65. Published
  66. Published

    Elevated HbA1c levels and the accumulation of differentiated T cells in CMV(+) individuals

    Jerrald Rector, G Neil Thomas, Paul Moss & Jos Bosch, Nov 2015, In: Diabetologia. 58, 11, p. 2596-605 10 p.

    Research output: Contribution to journalArticlepeer-review

  67. Published
  68. Published
  69. Published
  70. E-pub ahead of print
  71. Published
  72. Published
  73. Published
  74. Published

    Perturbation of the normal immune system in patients with CLL

    Paul Moss, 30 Jul 2015, In: Blood. 126, 5, p. 573-81 9 p.

    Research output: Contribution to journalArticlepeer-review

  75. Published

    Health state utilities for chronic lymphocytic leukemia: importance of prolonging progression-free survival

    Paul Moss, May 2015, In: Leukemia and Lymphoma. 56, 5, p. 1320-6 7 p.

    Research output: Contribution to journalArticlepeer-review

  76. Published
  77. Published
  78. Published

    Impact of Cytomegalovirus on Long-Term Mortality and Cancer Risk After Organ Transplantation

    Philip Johnson, Paul Moss, 20 Feb 2015, In: Transplantation.

    Research output: Contribution to journalArticlepeer-review

  79. Published
  80. Published

    Primary care management of early stage chronic lymphocytic leukaemia is safe and effective

    Helen Parry, Sarah Damery, Dickens Pratt, Paul Moss, 31 Jan 2015, In: QJM. 108, 10, p. 789-794 6 p.

    Research output: Contribution to journalArticlepeer-review

  81. Published
  82. Published

    Elevated HbA(1c) levels and the accumulation of differentiated T cells in CMV(+) individuals.

    Jerrald Rector, G Neil Thomas, Victoria Burns, Paul Moss, 2015, In: Diabetologia. 58, 11, p. 2596-2605

    Research output: Contribution to journalArticlepeer-review

  83. 2014
  84. Published

    New advances in CMV and immunosenescence

    & 20 others, , Paul Moss, Jul 2014, In: Experimental gerontology. 55, p. 54-62 9 p.

    Research output: Contribution to journalArticlepeer-review

  85. Published
  86. Published
  87. Published
  88. Published
  89. Published
  90. 2013
  91. Published
  92. Published
  93. Published
  94. Published
  95. Published

    HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy

    Geothy Chakupurakal, Mark Cobbold, Vivien Mautner & Paul Moss, Oct 2013, In: Journal of Immunotherapy. 36, 8, p. 423-31 9 p.

    Research output: Contribution to journalArticlepeer-review

  96. Published

    Cytomegalovirus infection and cognitive abilities in old age

    Paul Moss, Jul 2013, In: Neurobiology of Aging. 34, 7, p. 1846-52 7 p.

    Research output: Contribution to journalArticlepeer-review

  97. Published

    Cytomegalovirus infection is associated with increased mortality in the older population

    Annette Pachnio, Paul Moss, Jun 2013, In: Aging Cell. 12, 3, p. 381-7 7 p.

    Research output: Contribution to journalArticlepeer-review

  98. Published
  99. Published
  100. Published

    Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly

    Paul Moss, 2013, In: Immunity & Ageing. 10, 1, p. 33

    Research output: Contribution to journalArticlepeer-review

  101. 2012
  102. Published
  103. Published
  104. Published
  105. Published
  106. Published
  107. Published
  108. Published

    CMV and Immunosenescence: from basics to clinics

    Mark Beswick, Jos Bosch & 18 others, , Paul Moss, Jerrald Rector, Delphine Sauce & Keith Wheatley, 2012, In: Immunity & Ageing. 9, 1, p. 23

    Research output: Contribution to journalArticlepeer-review

  109. Published
  110. Published
  111. Published
  112. Published
  113. Published
  114. 2011
  115. Published
  116. Published
  117. Published
  118. Published
  119. Published
  120. Published
  121. Published
  122. Published

    Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96

    Paul Moss, 2011, In: Journal of Immunology. 187, 1, p. 7-9 3 p.

    Research output: Contribution to journalArticlepeer-review

  123. Published
  124. 2010
  125. Published

    Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions

    Mark Cobbold & Paul Moss, 1 Dec 2010, In: Immunology. 131, 4, p. 537-548 12 p.

    Research output: Contribution to journalArticle

  126. Published
  127. Published
  128. Published
  129. Published
  130. Published
  131. Published
  132. Published
  133. Published
  134. Published
  135. Published

    Immunosenescence and Cytomegalovirus: where do we stand after a decade?

    Paul Moss, 2010, In: Immunity & Ageing. 7, p. 13

    Research output: Contribution to journalArticlepeer-review

  136. 2009
  137. Published
  138. Published
  139. Published
  140. Published
  141. Published
  142. Published
  143. 2008
  144. Published
  145. Published
  146. Published
  147. Published
  148. Published

    Genotypic analysis of two hypervariable human cytomegalovirus genes

    Paul Moss & 1 others, , 1 Sep 2008, In: Journal of Medical Virology. 80, 9, p. 1615-1623 9 p.

    Research output: Contribution to journalArticle

  149. Published
  150. Published
  151. Published
  152. Published

    Cytomegalovirus is associated with depression and anxiety in older adults

    Anna Whittaker, Doug Carroll & Paul Moss, 1 Jan 2008, In: Brain, Behaviour, and Immunity. 22, 1, p. 52-55 4 p.

    Research output: Contribution to journalArticlepeer-review

  153. 2007
  154. Published
  155. Published
  156. Published

    Immunodeficiency and immunotherapy in multiple myeloma.

    Dickens Pratt, Oliver Goodyear & Paul Moss, 1 Sep 2007, In: British Journal of Haematology. 138, 5, p. 563-79 17 p.

    Research output: Contribution to journalArticle

  157. Published
  158. Published
  159. Published
  160. Published
  161. Published

    The effects of work:rest duration on physiological and perceptual responses during intermittent exercise and performance

    Paul Moss, 2007, In: Journal of Sports Sciences. 25, 14, p. 1613-21 9 p.

    Research output: Contribution to journalArticlepeer-review

  162. 2006
  163. Published
  164. Published
  165. Published
  166. Published
  167. 2005
  168. Published
  169. Published
  170. Published
  171. Published
  172. Published
  173. Published
  174. Published
  175. Published

    Biology and management of relapsed acute myeloid leukaemia

    Charles Craddock, Paul Moss, 1 Apr 2005, In: British Journal of Haematology. 129, p. 18-34 17 p.

    Research output: Contribution to journalArticle

  176. Published
  177. Published
  178. Published

    Bezafibrate and Medroxyprogesterone acetate as novel therapies in B-cell CLL

    McNeill Hayden, Farhat Khanim, Nick Davies, Mark Drayson, Paul Moss & Christopher Bunce, 1 Jan 2005, p. 100. 1 p.

    Research output: Contribution to conference (unpublished)Paper

  179. Published

    Cellular immunotherapy for viral infection after HSC transplantation

    Paul Moss & Alan Rickinson, 1 Jan 2005, In: Nature Reviews Immunology. 5, p. 9-20 12 p.

    Research output: Contribution to journalReview article

  180. Published
  181. 2004
  182. Published

    Principles of immunotherapy.

    Paul Moss, 1 Jul 2004, In: Vox Sanguinis. 87 Suppl1, p. 26-9 4 p.

    Research output: Contribution to journalArticle

  183. Published
  184. Published
  185. Published

    CD8(+) T cell immunity to cytomegalovirus

    Naeem Khan & Paul Moss, 1 Jan 2004, In: Human Immunology. 65, p. 456-464 9 p.

    Research output: Contribution to journalArticle

  186. Published
  187. Published
  188. Published
  189. Published
  190. 2003
  191. Published

    The cellular immunotherapy of viral infection

    Paul Moss, Mark Cobbold & Charles Craddock, 1 Dec 2003, In: Transfusion Medicine. 13, 6, p. 405-415 11 p.

    Research output: Contribution to journalArticle

  192. Published
  193. Published
  194. Published
  195. Published
  196. Published
  197. Published
  198. Published
  199. Published

    Effects of sodium bicarbonate ingestion on prolonged intermittent exercise

    Paul Moss, 2003, In: Medicine and Science in Sports and Exercise. 35, 8, p. 1303-8 6 p.

    Research output: Contribution to journalArticlepeer-review

  200. 2002
  201. Published
  202. Published
  203. Published
  204. Published
  205. Published
  206. Published

    ATM mutations in sporadic lymphoid tumours

    Tatjana Stankovic, Grant Stewart, Philip Byrd, Paul Moss & Malcolm Taylor, 1 Jan 2002, In: Leukemia and Lymphoma. 43, p. 1563-1571 9 p.

    Research output: Contribution to journalArticle

  207. Published
  208. Published
  209. Published
  210. 2001
  211. Published

    Developments in the treatment of post-transplant viral disease.

    Paul Moss, 1 Dec 2001, In: Best Practice & Research: Clinical Haematology. 14, 4, p. 777-92 16 p.

    Research output: Contribution to journalArticle

  212. Published
  213. Published
  214. Published

    Redirecting T cell specificity by TCR gene transfer

    Paul Moss, 1 Oct 2001, In: Nature Immunology. 2, 10, p. 900-901 2 p.

    Research output: Contribution to journalArticle

  215. Published
  216. Published
  217. 2000
  218. Published
  219. Published